Company Monitoring Page for Alexion

job ratings for Alexion

11/13/19
industry:
Biotech
company:
Alexion
job rating:
7
Great benefits and culture

latest headlines for company on cafepharma

Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma
Pharma Voice
Thu, 12/12/24 - 11:33 am
Tags:
ASH 2024, Regeneron, lymphoma, Alexion, Ultomiris
Two former Alexion leaders fight through layoffs and a tough market to maintain a rare disease biotech
Pharma Voice
Tue, 11/5/24 - 10:02 am
Tags:
Rallybio, clinical trials, layoffs, Alexion
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
Fierce Pharma
Thu, 09/14/23 - 11:00 pm
Tags:
Alexion, AstraZeneca, Soliris, investors, legal
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
Tags:
EHA, AstraZeneca, Alexion, Soliris, Ultomiris, Novartis, iptacopan, PNH
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
Tags:
AstraZeneca, Alexion, PNH, Ultomiris, Soliris, Roche, Apellis, Novartis
AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
Mon, 10/3/22 - 10:26 am
Tags:
AstraZeneca, M&A, Alexion, LogicBio Therapeutics, genomic medicine
AstraZeneca's Alexion bet continues to pay off as danicopan improves hemoglobin levels in phase 3
Fierce Biotech
Mon, 09/19/22 - 09:25 am
Tags:
AstraZeneca, Alexion, danicopan, paroxysmal nocturnal hemoglobinuria
Data backs AZ’s Wilson disease drug, but with a question mark
Pharmaforum
Fri, 06/24/22 - 10:26 am
Tags:
AstraZeneca, Wilson disease, Alexion, ALXN1840
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
Fierce Biotech
Mon, 04/18/22 - 10:48 am
Tags:
AstraZeneca, Alexion, Arvinas, Connecticut
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Tue, 03/1/22 - 10:23 am
Tags:
Alexion, AstraZeneca, Neurimmune, N!006, monoclonal antibodies, transthyretin amyloid cardiomyopathy
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Tags:
Roche, Chugai, AstraZeneca, Alexion, patents, Ultomiris, Soliris
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
Biopharma Reporter
Mon, 01/10/22 - 11:43 am
Tags:
Alexion, AstraZeneca, Neurimmune, NI006, ATTR-CM
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
Fri, 12/3/21 - 10:45 am
Tags:
AstraZeneca, Alexion, Sobi, M&A
AstraZeneca’s Alexion concludes Caelum acquisition for $500m
Pharmaceutical Business Review
Thu, 10/7/21 - 11:22 am
Tags:
AstraZeneca, Alexion, Caelum Biosciences, M&A
AstraZeneca lays out $360M for 'next-gen' manufacturing plant in Dublin
Fierce Pharma
Tue, 09/21/21 - 10:50 pm
Tags:
AstraZeneca, Alexion, Ireland, drug manufacturing
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
Pharmaforum
Thu, 08/26/21 - 11:09 am
Tags:
AstraZeneca, Alexion, ALXN1840, Wilson disease
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says
Fierce Pharma
Sun, 07/25/21 - 11:44 am
Tags:
AstraZeneca, Soliris, Alexion, drug pricing, myasthenia gravis
AstraZeneca heralds new chapter as Alexion acquisition completed
Biopharma Reporter
Wed, 07/21/21 - 08:46 pm
Tags:
AstraZeneca, Alexion, M&A
Biopharma throws grease on the deal wheels
EP Vantage
Wed, 07/21/21 - 10:52 am
Tags:
M&A, Alexion, Achillion, Eli Lilly, Prevail Therapeutics
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Fierce Pharma
Wed, 07/21/21 - 12:01 am
Tags:
AstraZeneca, Alexion, Ultomiris

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.